Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorFundació Sant Joan de Déu

About this trial

The aim of this study is to investigate the efficacy, efficiency, and patient experience of a new intervention program on adolescents with high-complexity eating disorders (ED). A prospective group of adolescents with ED (N=60) will follow this treatment program including four different phases: 1) Inpatient treatment; 2) Family Treatment Apartment; 3) Home Treatment; 4) Recovery within the community. The investigators will use a retrospective, control group (N=60) that matched the prospective group in age, sex, ED diagnosis, and severe symptomatology. Primary variables regarding Body Mass Index (BMI), ED symptomatology, functionality, recovery (yes/no), type of outpatient services (low/mid/high intensity), number of readmissions, and patient experience will be assessed at discharge, and after 6 and 12 months. Secondary variables include anxiety, depression, readiness to recover, quality of life symptoms, caregiver skills, and functionality of the family

Eligibility criteria

Qualifiers

Patient diagnosed with an Eating Disorder (according to the DSM-5) through a semi-structured interview (K-SADS PL-5)

Aged between 12 and 17 years old

Both patients and parents are willing to participate in the study and sign the informed consent to accept participation

undergoing over a year of treatment, including partial and total hospitalization, without symptom stabilization, experiencing severe psychological distress, eating symptomatology, comorbidities, or family dysfunction during this period (clinical improvement of at least 50 on the CGAS functioning scale) OR

Disqualifiers

Acute ED pathology and biological decompensation that require urgent pediatric attention or admission to an acute psychiatric ward.

Aged between 12 and 17 years old

Diagnosed with an Eating Disorder (according to the DSM-5)

Received treatment in Sant Joan de Déu between 2012 and 2022

Trial design

Treatments tested in this trial

  • ED-MINERVA Program

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators

Fundació Sant Joan de Déu

Lead sponsor

University Ramon Llull

Collaborator